BACKGROUND: The interaction of nitric oxide with superoxide (O2-) is a major O2- scavenging mechanism that can minimize O2 (-)-mediated oxidative stress. Glomeruli produce both nitric oxide and O2- and generation of both radicals is increased in various forms of glomerular disease. O2- increases glomerular capillary permeability to albumin (P(alb)). The present studies tested the hypothesis that nitric oxide opposes this effect, thereby preserving the glomerular protein permeability barrier. METHODS: P(alb) was determined in isolated rat glomeruli by measuring the change in glomerular volume in response to an experimental oncotic gradient. Changes in P(alb) in response to O2- generated by tumor necrosis factor-alpha (TNF-alpha) or xanthine/xanthine oxidase (X/XO) was assessed under conditions of nitric oxide depletion and repletion. RESULTS: Incubation of rat glomeruli with the nitric oxide synthase (NOS) inhibitor L-N(G)-monomethyl arginine (L-NMMA) increased P(alb.) This effect was reversed by the nitric oxide donor diethylenetriamine NONOate (DETA-NONOate) and by the superoxide dismutase (SOD) mimetic Tempol. O2- generated after incubation with TNF-alpha or X/XO increased P(alb). This effect was blocked by DETA-NONOate. CONCLUSION: We demonstrate that nitric oxide protects the glomerular filtration barrier from injury caused by O2- and suggest that inhibition of nitric oxide synthesis could enhance O2(-)-mediated oxidative injury under pathologic conditions.
BACKGROUND: The interaction of nitric oxide with superoxide (O2-) is a major O2- scavenging mechanism that can minimize O2 (-)-mediated oxidative stress. Glomeruli produce both nitric oxide and O2- and generation of both radicals is increased in various forms of glomerular disease. O2- increases glomerular capillary permeability to albumin (P(alb)). The present studies tested the hypothesis that nitric oxide opposes this effect, thereby preserving the glomerular protein permeability barrier. METHODS: P(alb) was determined in isolated rat glomeruli by measuring the change in glomerular volume in response to an experimental oncotic gradient. Changes in P(alb) in response to O2- generated by tumor necrosis factor-alpha (TNF-alpha) or xanthine/xanthine oxidase (X/XO) was assessed under conditions of nitric oxide depletion and repletion. RESULTS: Incubation of rat glomeruli with the nitric oxide synthase (NOS) inhibitor L-N(G)-monomethyl arginine (L-NMMA) increased P(alb.) This effect was reversed by the nitric oxidedonordiethylenetriamine NONOate (DETA-NONOate) and by the superoxide dismutase (SOD) mimetic Tempol. O2- generated after incubation with TNF-alpha or X/XO increased P(alb). This effect was blocked by DETA-NONOate. CONCLUSION: We demonstrate that nitric oxide protects the glomerular filtration barrier from injury caused by O2- and suggest that inhibition of nitric oxide synthesis could enhance O2(-)-mediated oxidative injury under pathologic conditions.
Authors: Ahmed A Mostafa; Edward W Randell; Sudesh C Vasdev; Vicki D Gill; Yingchun Han; Vereesh Gadag; Ahmed A Raouf; Hala El Said Journal: Mol Cell Biochem Date: 2007-02-21 Impact factor: 3.396
Authors: Mukut Sharma; Zongmin Zhou; Hiroto Miura; Andreas Papapetropoulos; Ellen T McCarthy; Ram Sharma; Virginia J Savin; Elias A Lianos Journal: Am J Physiol Renal Physiol Date: 2009-03-18
Authors: Mukut Sharma; Ellen T McCarthy; D Sudarshan Reddy; Paresh K Patel; Virginia J Savin; Meetha Medhora; John R Falck Journal: Prostaglandins Other Lipid Mediat Date: 2009-06 Impact factor: 3.072
Authors: J Brett Heimlich; Joshua S Speed; Paul M O'Connor; Jennifer S Pollock; Tim M Townes; Steffen E Meiler; Abdullah Kutlar; David M Pollock Journal: Br J Pharmacol Date: 2016-01 Impact factor: 8.739
Authors: Fan Fan; Chun Cheng Andy Chen; Jin Zhang; Carlos M N Schreck; Eric A Roman; Jan M Williams; Takashi Hirata; Mukut Sharma; Daniel A Beard; Virginia J Savin; Richard J Roman Journal: Am J Physiol Renal Physiol Date: 2015-10-07
Authors: Mukut Sharma; Brian D Halligan; Bassam T Wakim; Virginia J Savin; Eric P Cohen; John E Moulder Journal: Proteomics Clin Appl Date: 2008-06-18 Impact factor: 3.494